Ex parte BECK et al. - Page 6




          Appeal No. 94-3222                                                          
          Application 07/815,630                                                      
          allergen” in Claim 6 (emphasis added), and the phrase                       
          “excludes molecules of greater than 100,000 daltons” in Claim               
          2.  We will refrain from considering the patentability of the               
          claimed subject matter under 35 U.S.C. § 101 and under 35                   
          U.S.C. § 112, first paragraph, until the examiner has first                 
          interpreted the meaning and breadth of the aforementioned                   
          terms and phrases in light of the description of the claimed                
          subject matter in the specification and the teachings of the                
          prior art.  Id. at 1235, 169 USPQ at 238.                                   
               Moreover, we do not understand how it is possible for the              
          examiner of this application to consider the meaning and                    
          breadth of the terms and phrases in appellants’ claims in                   
          light of the prior art or to determine whether this                         
          specification would have enabled persons skilled in the art at              
          the pertinent time to make and use the full scope of invention              
          claimed without having first determined the effective filing                
          date of the subject matter claimed.  Unless and until the                   
          effective filing date of the subject matter presently claimed               
          is established, what is and what is not prior art as to the                 
          subject matter presently claimed can be no more than                        
          speculative.                                                                


                                          - 6 -                                       





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007